Affordable Access

deepdyve-link deepdyve-link
Publisher Website

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.

Authors
  • 1
  • 1 Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva/Sackler Faculty of Medicine, 39 Jabotinski St., Petah Tikva, Israel. [email protected]
Type
Published Article
Journal
Breast Cancer Research and Treatment
1573-7217
Publisher
Springer-Verlag
Publication Date
Volume
140
Issue
1
Pages
83–92
Identifiers
DOI: 10.1007/s10549-013-2603-1
PMID: 23801158
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments